Archive for the ‘Uncategorized’ Category
Yesterday we reported that Cell was looking into problematic images in a recent paper on human embryonic stem cell cloning. We’ve now heard from the journal about the nature of the inquiry.
Mary Beth O’Leary, a spokeswoman for Cell Press — an Elsevier title — tells us that:
Based on our own initial in-house assessment of the issues raised in PubPeer and in initial discussions with the authors, it seems that there were some minor errors made by the authors when preparing the figures for initial submission. While we are continuing discussions with the authors, we do not believe these errors impact the scientific findings of the paper in any way.
Read the rest of this entry »
The New York Times Magazine has a great profile — featuring an in-depth interview — of Diederik Stapel this weekend. Check it out. (Or, if you’re visiting us because the magazine was kind enough to include a link to Retraction Watch, welcome! And find all of our Stapel coverage here.)
One of a number of highlights in the piece by Yudhijit Battacharjee: Read the rest of this entry »
Brian Deer’s name will no doubt be familiar to many Retraction Watch readers. Deer, of course, is the award-winning investigative reporter known for his reporting on numerous medical issues, including Andrew Wakefield’s now-retracted research into autism and vaccines.
Deer is giving a talk next week at the UK’s “Evidence Live” conference,and has a proposal that he hopes will make it more difficult for dishonest researchers to hide their misdeeds — and make it easier for journals to retract fraudulent papers. He has expressed concern before that voluntary codes have no teeth. Deer is proposing an amendment to the ICMJE’s Uniform Requirements for the Submission of Manuscripts to Biomedical Journals:
We try to avoid straying beyond science on this blog, but sometimes — as in the case of This American Life, which not long ago had to retract a segment featuring Mike Daisey that had been critical of the conditions in a Chinese factory linked to Apple — we can’t help ourselves. Like now.
A retraction might be the next tune for one Timothy Michael Poe, who has been a contestant on America’s Got Talent. According to the Associated Press, the aspiring country singer told the show’s judges that:
Joining him in the discussion, which will be in English, are: Read the rest of this entry »
Maybe they just hallucinated it.
The RAND Corporation has retracted a study linking Los Angeles pot dispensaries to drops in crime, the Los Angeles Times reports. The problem: RAND hadn’t included data from the Los Angeles Police Department (LAPD). The institute tells the Times, referring to RAND researchers:
“They made mistakes,” said Debra Knopman, a Rand vice president and director of the infrastructure, safety and environment division. “What we’re wrestling with is how the mistakes went undetected.”
The report was peer-reviewed, RAND said, and retractions are uncommon: Read the rest of this entry »
If you’re a Retraction Watch reader in New York or St. Louis, come see Retraction Watch live. On Thursday, October 20, Ivan will be on a SONYC panel at Rockefeller University [please see update at end]. On the 25th, he’ll give a talk at the Danforth Center in St. Louis.
More info: Read the rest of this entry »
It’s a nice way to celebrate our first anniversary this week: Ivan will appear today on Science Friday, the nationally syndicated NPR program hosted by Ira Flatow.
You can listen online, or find a station near you that carries it, if you’re in the U.S. It’s live, so call in — you know we love hearing from Retraction Watch readers. It will also be archived on the site, so you can listen later.
Update, 5:15 Eastern, 8/5/11: Here’s that archived audio (top left corner).
Earlier this week we reported on the latest retraction of an article by Naoki Mori, number 21 in a series. We could have waited a few days and saved ourselves some trouble.
The journal Leukemia Research has retracted a 2006 paper by Mori, titled “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.” From the notice, which is behind a paywall: Read the rest of this entry »